CEACAM5 and cancer: Various biomarkers such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), prostate-specific antigen (PSA), and prostate cancer antigen 3 (PCA3) have been widely identified as vital indicators for early cancers [1,5,6].